Trials / Conditions / Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
5 registered clinical trials studyying Recurrent Lung Non-Squamous Non-Small Cell Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lun NCT04625647 | SWOG Cancer Research Network | Phase 2 |
| Recruiting | Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer NCT04181060 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared NCT04310007 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung C NCT04173507 | SWOG Cancer Research Network | Phase 2 |
| Completed | Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell L NCT03468985 | National Cancer Institute (NCI) | Phase 2 |